Case Study: Demonstrating Autologous Cell Therapy Comparability Upon Changing Viral Vector Manufacturing Facilities

Time: 2:10 pm
day: Post-Conference Day

Details:

  • How to prioritize analytical assays applicable to the comparability study
  • Example of demonstrating analytical comparability for both the viral vector, and for the autologous cell therapy drug product

Speakers: